
COVID-19 research at the Sanger Institute
We are committed to tracking, understanding and combatting COVID-19. Our staff sequence thousands of virus genomes and use the data to trace transmission, inform public health measures and monitor for new variants of the virus. We also work to understand how the virus interacts with our cells, and to develop new diagnostics

Available to watch now - Functional genomic approaches to guide cancer drug discovery
Dr Garnett is a Group Leader at the Wellcome Sanger Institute in the Cancer, Ageing and Somatic Mutation programme. He and his team investigate how genetic alterations contribute to cancer and impact on patient responses to anti-cancer medicines.